1	The	_	_	DT	_	_	_	_	_
2	microbial	_	_	JJ	_	_	_	_	_
3	community	_	_	NN	_	_	_	_	_
4	that	_	_	WDT	_	_	_	_	_
5	lives	_	_	VBZ	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	human	_	_	JJ	_	_	_	_	_
9	body	_	_	NN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	called	_	_	VBN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	microbiota	_	_	NN	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	consists	_	_	VBZ	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	a	_	_	DT	_	_	_	_	_
18	large	_	_	JJ	_	_	_	_	_
19	variety	_	_	NN	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	microorganisms	_	_	NNS	_	_	_	_	_
22	including	_	_	VBG	_	_	_	_	_
23	bacteria	_	_	NNS	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	viruses	_	_	NNS	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	fungi	_	_	NNS	_	_	_	_	_
28	,	_	_	,	_	_	_	_	_
29	eukaryotes	_	_	NNS	_	_	_	_	_
30	and	_	_	CC	_	_	_	_	_
31	archae	_	_	NN	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	Every	_	_	DT	_	_	_	_	_
2	human	_	_	JJ	_	_	_	_	_
3	being	_	_	NN	_	_	_	_	_
4	harbors	_	_	VBZ	_	_	_	_	_
5	between	_	_	IN	_	_	_	_	_
6	10	_	_	CD	_	_	_	_	_
7	trillion	_	_	CD	_	_	_	_	_
8	and	_	_	CC	_	_	_	_	_
9	100	_	_	CD	_	_	_	_	_
10	trillion	_	_	CD	_	_	_	_	_
11	microbial	_	_	JJ	_	_	_	_	_
12	cells	_	_	NNS	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	which	_	_	WDT	_	_	_	_	_
15	is	_	_	VBZ	_	_	_	_	_
16	approximately	_	_	RB	_	_	_	_	_
17	equal	_	_	JJ	_	_	_	_	_
18	to	_	_	TO	_	_	_	_	_
19	10	_	_	CD	_	_	_	_	_
20	times	_	_	NNS	_	_	_	_	_
21	the	_	_	DT	_	_	_	_	_
22	total	_	_	JJ	_	_	_	_	_
23	number	_	_	NN	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	body	_	_	NN	_	_	_	_	_
26	cells	_	_	NNS	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	term	_	_	NN	_	_	_	_	_
3	microbiome	_	_	NN	_	_	_	_	_
4	refers	_	_	VBZ	_	_	_	_	_
5	to	_	_	TO	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	gene	_	_	NN	_	_	_	_	_
8	set	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	these	_	_	DT	_	_	_	_	_
11	microbial	_	_	JJ	_	_	_	_	_
12	cells	_	_	NNS	_	_	_	_	_
13	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	gut	_	_	NN	_	_	_	_	_
3	microbiome	_	_	NN	_	_	_	_	_
4	is	_	_	VBZ	_	_	_	_	_
5	estimated	_	_	VBN	_	_	_	_	_
6	to	_	_	TO	_	_	_	_	_
7	contain	_	_	VB	_	_	_	_	_
8	over	_	_	IN	_	_	_	_	_
9	150	_	_	CD	_	_	_	_	_
10	times	_	_	NNS	_	_	_	_	_
11	more	_	_	JJR	_	_	_	_	_
12	genes	_	_	NNS	_	_	_	_	_
13	than	_	_	IN	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	human	_	_	JJ	_	_	_	_	_
16	genome	_	_	NN	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	During	_	_	IN	_	_	_	_	_
2	long-standing	_	_	JJ	_	_	_	_	_
3	interactions	_	_	NNS	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	mutual	_	_	JJ	_	_	_	_	_
7	co-evolution	_	_	NN	_	_	_	_	_
8	between	_	_	IN	_	_	_	_	_
9	gut	_	_	NN	_	_	_	_	_
10	microbiota	_	_	NN	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	host	_	_	NN	_	_	_	_	_
14	occurs	_	_	VBZ	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	with	_	_	IN	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	former	_	_	JJ	_	_	_	_	_
19	making	_	_	VBG	_	_	_	_	_
20	an	_	_	DT	_	_	_	_	_
21	important	_	_	JJ	_	_	_	_	_
22	contribution	_	_	NN	_	_	_	_	_
23	to	_	_	TO	_	_	_	_	_
24	human	_	_	JJ	_	_	_	_	_
25	metabolism	_	_	NN	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	with	_	_	IN	_	_	_	_	_
28	significant	_	_	JJ	_	_	_	_	_
29	effects	_	_	NNS	_	_	_	_	_
30	on	_	_	IN	_	_	_	_	_
31	the	_	_	DT	_	_	_	_	_
32	anatomical	_	_	JJ	_	_	_	_	_
33	,	_	_	,	_	_	_	_	_
34	physiological	_	_	JJ	_	_	_	_	_
35	,	_	_	,	_	_	_	_	_
36	and	_	_	CC	_	_	_	_	_
37	immunological	_	_	JJ	_	_	_	_	_
38	development	_	_	NN	_	_	_	_	_
39	of	_	_	IN	_	_	_	_	_
40	the	_	_	DT	_	_	_	_	_
41	host	_	_	NN	_	_	_	_	_
42	.	_	_	.	_	_	_	_	_


1	Considering	_	_	VBG	_	_	_	_	_
2	that	_	_	IN	_	_	_	_	_
3	many	_	_	JJ	_	_	_	_	_
4	bacterial	_	_	JJ	_	_	_	_	_
5	species	_	_	NNS	_	_	_	_	_
6	still	_	_	RB	_	_	_	_	_
7	cannot	_	_	MD	_	_	_	_	_
8	be	_	_	VB	_	_	_	_	_
9	cultured	_	_	VBN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	our	_	_	PRP$	_	_	_	_	_
12	understanding	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	gut	_	_	NN	_	_	_	_	_
15	microbiota	_	_	NN	_	_	_	_	_
16	has	_	_	VBZ	_	_	_	_	_
17	evolved	_	_	VBN	_	_	_	_	_
18	over	_	_	IN	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	past	_	_	JJ	_	_	_	_	_
21	few	_	_	JJ	_	_	_	_	_
22	years	_	_	NNS	_	_	_	_	_
23	thanks	_	_	NNS	_	_	_	_	_
24	to	_	_	TO	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	availability	_	_	NN	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	advanced	_	_	JJ	_	_	_	_	_
29	molecular	_	_	JJ	_	_	_	_	_
30	methods	_	_	NNS	_	_	_	_	_
31	that	_	_	WDT	_	_	_	_	_
32	permit	_	_	VBP	_	_	_	_	_
33	us	_	_	PRP	_	_	_	_	_
34	to	_	_	TO	_	_	_	_	_
35	identify	_	_	VB	_	_	_	_	_
36	a	_	_	DT	_	_	_	_	_
37	large	_	_	JJ	_	_	_	_	_
38	quantity	_	_	NN	_	_	_	_	_
39	of	_	_	IN	_	_	_	_	_
40	microorganisms	_	_	NNS	_	_	_	_	_
41	.	_	_	.	_	_	_	_	_


1	Today	_	_	NN	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	it	_	_	PRP	_	_	_	_	_
4	is	_	_	VBZ	_	_	_	_	_
5	known	_	_	VBN	_	_	_	_	_
6	that	_	_	IN	_	_	_	_	_
7	although	_	_	IN	_	_	_	_	_
8	98	_	_	CD	_	_	_	_	_
9	%	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	gut	_	_	NN	_	_	_	_	_
13	microbiota	_	_	NN	_	_	_	_	_
14	is	_	_	VBZ	_	_	_	_	_
15	composed	_	_	VBN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	four	_	_	CD	_	_	_	_	_
18	phyla	_	_	NNS	_	_	_	_	_
19	of	_	_	IN	_	_	_	_	_
20	bacteria	_	_	NN	_	_	_	_	_
21	(	_	_	-LRB-	_	_	_	_	_
22	Firmicutes	_	_	NNP	_	_	_	_	_
23	,	_	_	,	_	_	_	_	_
24	Bacteroidetes	_	_	NNP	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	Proteobacteria	_	_	NN	_	_	_	_	_
27	and	_	_	CC	_	_	_	_	_
28	Actinobacteria	_	_	NN	_	_	_	_	_
29	)	_	_	-RRB-	_	_	_	_	_
30	,	_	_	,	_	_	_	_	_
31	the	_	_	DT	_	_	_	_	_
32	majority	_	_	NN	_	_	_	_	_
33	are	_	_	VBP	_	_	_	_	_
34	either	_	_	CC	_	_	_	_	_
35	Firmicutes	_	_	NNP	_	_	_	_	_
36	or	_	_	CC	_	_	_	_	_
37	Bacteroidetes	_	_	NNP	_	_	_	_	_
38	.	_	_	.	_	_	_	_	_


1	With	_	_	IN	_	_	_	_	_
2	this	_	_	DT	_	_	_	_	_
3	premise	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	in	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	last	_	_	JJ	_	_	_	_	_
8	decade	_	_	NN	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	gut	_	_	NN	_	_	_	_	_
12	microbiota	_	_	NN	_	_	_	_	_
13	has	_	_	VBZ	_	_	_	_	_
14	become	_	_	VBN	_	_	_	_	_
15	a	_	_	DT	_	_	_	_	_
16	key	_	_	JJ	_	_	_	_	_
17	topic	_	_	NN	_	_	_	_	_
18	in	_	_	IN	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	investigation	_	_	NN	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	several	_	_	JJ	_	_	_	_	_
23	gastrointestinal	_	_	JJ	_	_	_	_	_
24	(	_	_	-LRB-	_	_	_	_	_
25	GI	_	_	NN	_	_	_	_	_
26	)	_	_	-RRB-	_	_	_	_	_
27	as	_	_	RB	_	_	_	_	_
28	well	_	_	RB	_	_	_	_	_
29	as	_	_	IN	_	_	_	_	_
30	extra-GI	_	_	JJ	_	_	_	_	_
31	diseases	_	_	NNS	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	Irritable	_	_	JJ	_	_	_	_	_
2	bowel	_	_	NN	_	_	_	_	_
3	syndrome	_	_	NN	_	_	_	_	_
4	(	_	_	-LRB-	_	_	_	_	_
5	IBS	_	_	NNP	_	_	_	_	_
6	)	_	_	-RRB-	_	_	_	_	_
7	is	_	_	VBZ	_	_	_	_	_
8	a	_	_	DT	_	_	_	_	_
9	common	_	_	JJ	_	_	_	_	_
10	functional	_	_	JJ	_	_	_	_	_
11	clinical	_	_	JJ	_	_	_	_	_
12	condition	_	_	NN	_	_	_	_	_
13	characterized	_	_	VBN	_	_	_	_	_
14	by	_	_	IN	_	_	_	_	_
15	abdominal	_	_	JJ	_	_	_	_	_
16	discomfort	_	_	NN	_	_	_	_	_
17	or	_	_	CC	_	_	_	_	_
18	pain	_	_	NN	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	alteration	_	_	NN	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	gut	_	_	NN	_	_	_	_	_
23	habits	_	_	NNS	_	_	_	_	_
24	without	_	_	IN	_	_	_	_	_
25	an	_	_	DT	_	_	_	_	_
26	underlying	_	_	JJ	_	_	_	_	_
27	structural	_	_	JJ	_	_	_	_	_
28	pathology	_	_	NN	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	As	_	_	IN	_	_	_	_	_
2	IBS	_	_	NNP	_	_	_	_	_
3	affects	_	_	VBZ	_	_	_	_	_
4	9	_	_	CD	_	_	_	_	_
5	–	_	_	TO	_	_	_	_	_
6	23	_	_	CD	_	_	_	_	_
7	%	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	general	_	_	JJ	_	_	_	_	_
11	population	_	_	NN	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	with	_	_	IN	_	_	_	_	_
14	considerable	_	_	JJ	_	_	_	_	_
15	impact	_	_	NN	_	_	_	_	_
16	on	_	_	IN	_	_	_	_	_
17	quality	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	life	_	_	NN	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	health	_	_	NN	_	_	_	_	_
22	care	_	_	NN	_	_	_	_	_
23	resource	_	_	NN	_	_	_	_	_
24	utilization	_	_	NN	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	it	_	_	PRP	_	_	_	_	_
27	represents	_	_	VBZ	_	_	_	_	_
28	an	_	_	DT	_	_	_	_	_
29	important	_	_	JJ	_	_	_	_	_
30	medical	_	_	JJ	_	_	_	_	_
31	challenge	_	_	NN	_	_	_	_	_
32	in	_	_	IN	_	_	_	_	_
33	term	_	_	NN	_	_	_	_	_
34	of	_	_	IN	_	_	_	_	_
35	diagnosis	_	_	NN	_	_	_	_	_
36	and	_	_	CC	_	_	_	_	_
37	treatment	_	_	NN	_	_	_	_	_
38	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	pathogenesis	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	IBS	_	_	NNP	_	_	_	_	_
5	remains	_	_	VBZ	_	_	_	_	_
6	unclear	_	_	JJ	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	with	_	_	IN	_	_	_	_	_
9	several	_	_	JJ	_	_	_	_	_
10	factors	_	_	NNS	_	_	_	_	_
11	supposed	_	_	VBN	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	be	_	_	VB	_	_	_	_	_
14	involved	_	_	VBN	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	including	_	_	VBG	_	_	_	_	_
17	environmental	_	_	JJ	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	host	_	_	JJ	_	_	_	_	_
20	factors	_	_	NNS	_	_	_	_	_
21	such	_	_	JJ	_	_	_	_	_
22	as	_	_	IN	_	_	_	_	_
23	psychosocial	_	_	JJ	_	_	_	_	_
24	stressors	_	_	NNS	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	food	_	_	NN	_	_	_	_	_
27	intolerance	_	_	NN	_	_	_	_	_
28	,	_	_	,	_	_	_	_	_
29	antibiotics	_	_	NNS	_	_	_	_	_
30	,	_	_	,	_	_	_	_	_
31	enteric	_	_	JJ	_	_	_	_	_
32	infections	_	_	NNS	_	_	_	_	_
33	,	_	_	,	_	_	_	_	_
34	altered	_	_	VBN	_	_	_	_	_
35	pain	_	_	NN	_	_	_	_	_
36	perception	_	_	NN	_	_	_	_	_
37	,	_	_	,	_	_	_	_	_
38	altered	_	_	VBN	_	_	_	_	_
39	brain	_	_	NN	_	_	_	_	_
40	–	_	_	:	_	_	_	_	_
41	gut	_	_	NN	_	_	_	_	_
42	interactions	_	_	NNS	_	_	_	_	_
43	,	_	_	,	_	_	_	_	_
44	dysbiosis	_	_	NN	_	_	_	_	_
45	(	_	_	-LRB-	_	_	_	_	_
46	imbalance	_	_	NN	_	_	_	_	_
47	within	_	_	IN	_	_	_	_	_
48	the	_	_	DT	_	_	_	_	_
49	bacterial	_	_	JJ	_	_	_	_	_
50	community	_	_	NN	_	_	_	_	_
51	)	_	_	-RRB-	_	_	_	_	_
52	,	_	_	,	_	_	_	_	_
53	increased	_	_	VBN	_	_	_	_	_
54	intestinal	_	_	JJ	_	_	_	_	_
55	permeability	_	_	NN	_	_	_	_	_
56	,	_	_	,	_	_	_	_	_
57	increased	_	_	VBN	_	_	_	_	_
58	gut	_	_	NN	_	_	_	_	_
59	mucosal	_	_	JJ	_	_	_	_	_
60	immune	_	_	JJ	_	_	_	_	_
61	activation	_	_	NN	_	_	_	_	_
62	and	_	_	CC	_	_	_	_	_
63	visceral	_	_	JJ	_	_	_	_	_
64	hypersensitivity	_	_	NN	_	_	_	_	_
65	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	recent	_	_	JJ	_	_	_	_	_
3	years	_	_	NNS	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	relationship	_	_	NN	_	_	_	_	_
7	between	_	_	IN	_	_	_	_	_
8	gut	_	_	NN	_	_	_	_	_
9	microbiota	_	_	NN	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	brain	_	_	NN	_	_	_	_	_
12	–	_	_	:	_	_	_	_	_
13	gut	_	_	NN	_	_	_	_	_
14	interactions	_	_	NNS	_	_	_	_	_
15	in	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	pathogenesis	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	IBS	_	_	NNP	_	_	_	_	_
20	has	_	_	VBZ	_	_	_	_	_
21	become	_	_	VBN	_	_	_	_	_
22	a	_	_	DT	_	_	_	_	_
23	key	_	_	JJ	_	_	_	_	_
24	topic	_	_	NN	_	_	_	_	_
25	in	_	_	IN	_	_	_	_	_
26	clinical	_	_	JJ	_	_	_	_	_
27	and	_	_	CC	_	_	_	_	_
28	biomedical	_	_	JJ	_	_	_	_	_
29	research	_	_	NN	_	_	_	_	_
30	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	issue	_	_	NN	_	_	_	_	_
3	has	_	_	VBZ	_	_	_	_	_
4	been	_	_	VBN	_	_	_	_	_
5	accurately	_	_	RB	_	_	_	_	_
6	discussed	_	_	VBN	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	a	_	_	DT	_	_	_	_	_
9	recent	_	_	JJ	_	_	_	_	_
10	review	_	_	NN	_	_	_	_	_
11	by	_	_	IN	_	_	_	_	_
12	Quigley	_	_	NNP	_	_	_	_	_
13	.	_	_	.	_	_	_	_	_


1	Beginning	_	_	VBG	_	_	_	_	_
2	with	_	_	IN	_	_	_	_	_
3	an	_	_	DT	_	_	_	_	_
4	excursus	_	_	NN	_	_	_	_	_
5	on	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	historical	_	_	JJ	_	_	_	_	_
8	steps	_	_	NNS	_	_	_	_	_
9	that	_	_	WDT	_	_	_	_	_
10	led	_	_	VBD	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	definition	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	gut	_	_	NN	_	_	_	_	_
17	–	_	_	:	_	_	_	_	_
18	brain	_	_	NN	_	_	_	_	_
19	axis	_	_	NN	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	the	_	_	DT	_	_	_	_	_
22	author	_	_	NN	_	_	_	_	_
23	discussed	_	_	VBD	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	modern	_	_	JJ	_	_	_	_	_
26	theory	_	_	NN	_	_	_	_	_
27	that	_	_	WDT	_	_	_	_	_
28	postulates	_	_	VBZ	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	involvement	_	_	NN	_	_	_	_	_
31	of	_	_	IN	_	_	_	_	_
32	gut	_	_	NN	_	_	_	_	_
33	microbiota	_	_	NN	_	_	_	_	_
34	in	_	_	IN	_	_	_	_	_
35	both	_	_	CC	_	_	_	_	_
36	the	_	_	DT	_	_	_	_	_
37	gut	_	_	NN	_	_	_	_	_
38	–	_	_	:	_	_	_	_	_
39	brain	_	_	NN	_	_	_	_	_
40	axis	_	_	NN	_	_	_	_	_
41	and	_	_	CC	_	_	_	_	_
42	IBS	_	_	NNP	_	_	_	_	_
43	.	_	_	.	_	_	_	_	_


1	On	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	basis	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	this	_	_	DT	_	_	_	_	_
6	theory	_	_	NN	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	pathogenesis	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	IBS	_	_	NNP	_	_	_	_	_
12	would	_	_	MD	_	_	_	_	_
13	be	_	_	VB	_	_	_	_	_
14	related	_	_	VBN	_	_	_	_	_
15	to	_	_	TO	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	action	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	central	_	_	JJ	_	_	_	_	_
20	stimuli	_	_	NNS	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	such	_	_	JJ	_	_	_	_	_
23	as	_	_	IN	_	_	_	_	_
24	stress	_	_	NN	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	that	_	_	WDT	_	_	_	_	_
27	could	_	_	MD	_	_	_	_	_
28	disrupt	_	_	VB	_	_	_	_	_
29	mucosal	_	_	JJ	_	_	_	_	_
30	immunity	_	_	NN	_	_	_	_	_
31	,	_	_	,	_	_	_	_	_
32	reduce	_	_	VB	_	_	_	_	_
33	microbial	_	_	JJ	_	_	_	_	_
34	diversity	_	_	NN	_	_	_	_	_
35	and	_	_	CC	_	_	_	_	_
36	alter	_	_	VB	_	_	_	_	_
37	gut	_	_	NN	_	_	_	_	_
38	barrier	_	_	NN	_	_	_	_	_
39	function	_	_	NN	_	_	_	_	_
40	,	_	_	,	_	_	_	_	_
41	leading	_	_	VBG	_	_	_	_	_
42	to	_	_	TO	_	_	_	_	_
43	gut	_	_	VB	_	_	_	_	_
44	dysfunction	_	_	NN	_	_	_	_	_
45	.	_	_	.	_	_	_	_	_


1	Although	_	_	IN	_	_	_	_	_
2	much	_	_	JJ	_	_	_	_	_
3	work	_	_	NN	_	_	_	_	_
4	still	_	_	RB	_	_	_	_	_
5	needs	_	_	VBZ	_	_	_	_	_
6	to	_	_	TO	_	_	_	_	_
7	be	_	_	VB	_	_	_	_	_
8	done	_	_	VBN	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	there	_	_	EX	_	_	_	_	_
11	is	_	_	VBZ	_	_	_	_	_
12	evidence	_	_	NN	_	_	_	_	_
13	to	_	_	TO	_	_	_	_	_
14	support	_	_	VB	_	_	_	_	_
15	this	_	_	DT	_	_	_	_	_
16	pathogenetic	_	_	JJ	_	_	_	_	_
17	model	_	_	NN	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	First	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	it	_	_	PRP	_	_	_	_	_
4	has	_	_	VBZ	_	_	_	_	_
5	been	_	_	VBN	_	_	_	_	_
6	shown	_	_	VBN	_	_	_	_	_
7	that	_	_	IN	_	_	_	_	_
8	fecal	_	_	JJ	_	_	_	_	_
9	and	_	_	CC	_	_	_	_	_
10	colonic	_	_	JJ	_	_	_	_	_
11	microbiota	_	_	NN	_	_	_	_	_
12	compositions	_	_	NNS	_	_	_	_	_
13	in	_	_	IN	_	_	_	_	_
14	patients	_	_	NNS	_	_	_	_	_
15	with	_	_	IN	_	_	_	_	_
16	IBS	_	_	NNP	_	_	_	_	_
17	are	_	_	VBP	_	_	_	_	_
18	different	_	_	JJ	_	_	_	_	_
19	compared	_	_	VBN	_	_	_	_	_
20	to	_	_	TO	_	_	_	_	_
21	healthy	_	_	JJ	_	_	_	_	_
22	subjects	_	_	NNS	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	For	_	_	IN	_	_	_	_	_
2	example	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	count	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	gene	_	_	NN	_	_	_	_	_
8	copies	_	_	NNS	_	_	_	_	_
9	or	_	_	CC	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	number	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	colony	_	_	NN	_	_	_	_	_
14	forming	_	_	VBG	_	_	_	_	_
15	units	_	_	NNS	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	Lactobacilli	_	_	NNP	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	Bifidobacteria	_	_	NN	_	_	_	_	_
20	are	_	_	VBP	_	_	_	_	_
21	compromised	_	_	VBN	_	_	_	_	_
22	while	_	_	IN	_	_	_	_	_
23	those	_	_	DT	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	Escherichia	_	_	NNP	_	_	_	_	_
26	coli	_	_	NNP	_	_	_	_	_
27	and	_	_	CC	_	_	_	_	_
28	Enterobacter	_	_	NN	_	_	_	_	_
29	are	_	_	VBP	_	_	_	_	_
30	increased	_	_	VBN	_	_	_	_	_
31	in	_	_	IN	_	_	_	_	_
32	IBS	_	_	NNP	_	_	_	_	_
33	patients	_	_	NNS	_	_	_	_	_
34	.	_	_	.	_	_	_	_	_


1	Furthermore	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	a	_	_	DT	_	_	_	_	_
4	specific	_	_	JJ	_	_	_	_	_
5	gut	_	_	NN	_	_	_	_	_
6	microbiota	_	_	NN	_	_	_	_	_
7	signature	_	_	NN	_	_	_	_	_
8	(	_	_	-LRB-	_	_	_	_	_
9	low	_	_	JJ	_	_	_	_	_
10	microbial	_	_	JJ	_	_	_	_	_
11	diversity	_	_	NN	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	absence	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	Methanobacteriales	_	_	NNS	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	enrichment	_	_	NN	_	_	_	_	_
18	with	_	_	IN	_	_	_	_	_
19	Bacteroides	_	_	NNS	_	_	_	_	_
20	)	_	_	-RRB-	_	_	_	_	_
21	could	_	_	MD	_	_	_	_	_
22	be	_	_	VB	_	_	_	_	_
23	linked	_	_	VBN	_	_	_	_	_
24	to	_	_	TO	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	severity	_	_	NN	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	IBS	_	_	NNP	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	Second	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	benefits	_	_	NNS	_	_	_	_	_
5	reported	_	_	VBN	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	some	_	_	DT	_	_	_	_	_
8	studies	_	_	NNS	_	_	_	_	_
9	after	_	_	IN	_	_	_	_	_
10	antibiotic	_	_	JJ	_	_	_	_	_
11	or	_	_	CC	_	_	_	_	_
12	probiotic	_	_	JJ	_	_	_	_	_
13	administration	_	_	NN	_	_	_	_	_
14	on	_	_	IN	_	_	_	_	_
15	IBS	_	_	NNP	_	_	_	_	_
16	symptoms	_	_	NNS	_	_	_	_	_
17	are	_	_	VBP	_	_	_	_	_
18	proof	_	_	NN	_	_	_	_	_
19	in	_	_	IN	_	_	_	_	_
20	favor	_	_	NN	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	a	_	_	DT	_	_	_	_	_
23	role	_	_	NN	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	microbiota	_	_	NN	_	_	_	_	_
26	in	_	_	IN	_	_	_	_	_
27	the	_	_	DT	_	_	_	_	_
28	pathogenesis	_	_	NN	_	_	_	_	_
29	of	_	_	IN	_	_	_	_	_
30	this	_	_	DT	_	_	_	_	_
31	disease	_	_	NN	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_
33	Data	_	_	NN	_	_	_	_	_
34	from	_	_	IN	_	_	_	_	_
35	animal	_	_	NN	_	_	_	_	_
36	models	_	_	NNS	_	_	_	_	_
37	provides	_	_	VBZ	_	_	_	_	_
38	a	_	_	DT	_	_	_	_	_
39	plausible	_	_	JJ	_	_	_	_	_
40	explanation	_	_	NN	_	_	_	_	_
41	for	_	_	IN	_	_	_	_	_
42	this	_	_	DT	_	_	_	_	_
43	benefit	_	_	NN	_	_	_	_	_
44	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	has	_	_	VBZ	_	_	_	_	_
3	been	_	_	VBN	_	_	_	_	_
4	shown	_	_	VBN	_	_	_	_	_
5	that	_	_	IN	_	_	_	_	_
6	probiotics	_	_	NNS	_	_	_	_	_
7	can	_	_	MD	_	_	_	_	_
8	enhance	_	_	VB	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	intestinal	_	_	JJ	_	_	_	_	_
11	mucosal	_	_	JJ	_	_	_	_	_
12	barrier	_	_	NN	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	increase	_	_	VB	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	number	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	butyrate-producing	_	_	JJ	_	_	_	_	_
19	bacteria	_	_	NNS	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	augmented	_	_	VBN	_	_	_	_	_
3	production	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	short-chain	_	_	JJ	_	_	_	_	_
6	fatty	_	_	NN	_	_	_	_	_
7	acids	_	_	NNS	_	_	_	_	_
8	(	_	_	-LRB-	_	_	_	_	_
9	SCFAs	_	_	NNP	_	_	_	_	_
10	)	_	_	-RRB-	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	such	_	_	JJ	_	_	_	_	_
13	as	_	_	IN	_	_	_	_	_
14	butyric	_	_	NN	_	_	_	_	_
15	and	_	_	CC	_	_	_	_	_
16	acetic	_	_	NN	_	_	_	_	_
17	acid	_	_	NN	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	acidizes	_	_	VBZ	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	gut	_	_	NN	_	_	_	_	_
22	and	_	_	CC	_	_	_	_	_
23	facilitates	_	_	VBZ	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	beneficial	_	_	JJ	_	_	_	_	_
26	colonization	_	_	NN	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	Lactobacillus	_	_	NNP	_	_	_	_	_
29	and	_	_	CC	_	_	_	_	_
30	Bifidobacterium	_	_	NN	_	_	_	_	_
31	species	_	_	NNS	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	Whatever	_	_	WDT	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	precise	_	_	JJ	_	_	_	_	_
4	mechanism	_	_	NN	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	poorly	_	_	RB	_	_	_	_	_
8	absorbed	_	_	VBN	_	_	_	_	_
9	antibiotic	_	_	JJ	_	_	_	_	_
10	rifaximin	_	_	NN	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	probiotics	_	_	NNS	_	_	_	_	_
13	or	_	_	CC	_	_	_	_	_
14	prebiotics	_	_	NNS	_	_	_	_	_
15	provided	_	_	VBN	_	_	_	_	_
16	relief	_	_	NN	_	_	_	_	_
17	against	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	cardinal	_	_	JJ	_	_	_	_	_
20	IBS	_	_	NN	_	_	_	_	_
21	symptoms	_	_	NNS	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	For	_	_	IN	_	_	_	_	_
2	these	_	_	DT	_	_	_	_	_
3	reasons	_	_	NNS	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	recent	_	_	JJ	_	_	_	_	_
6	international	_	_	JJ	_	_	_	_	_
7	guidelines	_	_	NNS	_	_	_	_	_
8	suggest	_	_	VBP	_	_	_	_	_
9	to	_	_	TO	_	_	_	_	_
10	prescribe	_	_	VB	_	_	_	_	_
11	probiotics	_	_	NNS	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	this	_	_	DT	_	_	_	_	_
14	context	_	_	NN	_	_	_	_	_
15	.	_	_	.	_	_	_	_	_


1	Third	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	gut	_	_	NN	_	_	_	_	_
5	microbiota	_	_	NN	_	_	_	_	_
6	plays	_	_	VBZ	_	_	_	_	_
7	a	_	_	DT	_	_	_	_	_
8	key	_	_	JJ	_	_	_	_	_
9	role	_	_	NN	_	_	_	_	_
10	in	_	_	IN	_	_	_	_	_
11	digestion	_	_	NN	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	absorption	_	_	NN	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	synthesis	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	metabolites	_	_	NNS	_	_	_	_	_
18	such	_	_	JJ	_	_	_	_	_
19	as	_	_	IN	_	_	_	_	_
20	SCFAs	_	_	NNP	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_


1	These	_	_	DT	_	_	_	_	_
2	metabolites	_	_	NNS	_	_	_	_	_
3	are	_	_	VBP	_	_	_	_	_
4	directly	_	_	RB	_	_	_	_	_
5	associated	_	_	VBN	_	_	_	_	_
6	with	_	_	IN	_	_	_	_	_
7	environmental	_	_	JJ	_	_	_	_	_
8	factors	_	_	NNS	_	_	_	_	_
9	such	_	_	JJ	_	_	_	_	_
10	as	_	_	IN	_	_	_	_	_
11	diet	_	_	NN	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	lifestyle	_	_	NN	_	_	_	_	_
14	.	_	_	.	_	_	_	_	_


1	Growing	_	_	VBG	_	_	_	_	_
2	evidence	_	_	NN	_	_	_	_	_
3	supports	_	_	VBZ	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	concept	_	_	NN	_	_	_	_	_
6	that	_	_	IN	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	patients	_	_	NNS	_	_	_	_	_
10	with	_	_	IN	_	_	_	_	_
11	IBS	_	_	NNP	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	specific	_	_	JJ	_	_	_	_	_
14	diets	_	_	NNS	_	_	_	_	_
15	could	_	_	MD	_	_	_	_	_
16	be	_	_	VB	_	_	_	_	_
17	associated	_	_	VBN	_	_	_	_	_
18	to	_	_	TO	_	_	_	_	_
19	microbiota	_	_	NN	_	_	_	_	_
20	modulation	_	_	NN	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	thus	_	_	RB	_	_	_	_	_
23	adding	_	_	VBG	_	_	_	_	_
24	another	_	_	DT	_	_	_	_	_
25	piece	_	_	NN	_	_	_	_	_
26	of	_	_	IN	_	_	_	_	_
27	the	_	_	DT	_	_	_	_	_
28	puzzle	_	_	NN	_	_	_	_	_
29	to	_	_	TO	_	_	_	_	_
30	the	_	_	DT	_	_	_	_	_
31	gut	_	_	NN	_	_	_	_	_
32	microbiota-IBS	_	_	NN	_	_	_	_	_
33	link	_	_	NN	_	_	_	_	_
34	.	_	_	.	_	_	_	_	_


1	Of	_	_	IN	_	_	_	_	_
2	increasing	_	_	VBG	_	_	_	_	_
3	interest	_	_	NN	_	_	_	_	_
4	is	_	_	VBZ	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	low	_	_	JJ	_	_	_	_	_
7	fermentable	_	_	JJ	_	_	_	_	_
8	oligosaccharides	_	_	NNS	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	disaccharides	_	_	NNS	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	monosaccharides	_	_	NNS	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	polyols	_	_	NNS	_	_	_	_	_
15	(	_	_	-LRB-	_	_	_	_	_
16	FODMAPs	_	_	NNP	_	_	_	_	_
17	)	_	_	-RRB-	_	_	_	_	_
18	diet	_	_	NN	_	_	_	_	_
19	that	_	_	WDT	_	_	_	_	_
20	leads	_	_	VBZ	_	_	_	_	_
21	to	_	_	TO	_	_	_	_	_
22	reduced	_	_	VBN	_	_	_	_	_
23	flatulence	_	_	NN	_	_	_	_	_
24	and	_	_	CC	_	_	_	_	_
25	symptom	_	_	NN	_	_	_	_	_
26	relief	_	_	NN	_	_	_	_	_
27	in	_	_	IN	_	_	_	_	_
28	some	_	_	DT	_	_	_	_	_
29	IBS	_	_	NNP	_	_	_	_	_
30	patients	_	_	NNS	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	Nevertheless	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	while	_	_	IN	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	beneficial	_	_	JJ	_	_	_	_	_
6	role	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	this	_	_	DT	_	_	_	_	_
9	diet	_	_	NN	_	_	_	_	_
10	on	_	_	IN	_	_	_	_	_
11	microbiota	_	_	NN	_	_	_	_	_
12	remains	_	_	VBZ	_	_	_	_	_
13	unclear	_	_	JJ	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	a	_	_	DT	_	_	_	_	_
16	reduction	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	commensal	_	_	JJ	_	_	_	_	_
19	bacteria	_	_	NN	_	_	_	_	_
20	has	_	_	VBZ	_	_	_	_	_
21	been	_	_	VBN	_	_	_	_	_
22	reported	_	_	VBN	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_
24	Hustoft	_	_	NNP	_	_	_	_	_
25	et	_	_	FW	_	_	_	_	_
26	al.	_	_	FW	_	_	_	_	_
27	have	_	_	VBP	_	_	_	_	_
28	shown	_	_	VBN	_	_	_	_	_
29	a	_	_	DT	_	_	_	_	_
30	reduction	_	_	NN	_	_	_	_	_
31	in	_	_	IN	_	_	_	_	_
32	fecal	_	_	JJ	_	_	_	_	_
33	Actinobacteria	_	_	NN	_	_	_	_	_
34	,	_	_	,	_	_	_	_	_
35	Bifidobacterium	_	_	NNP	_	_	_	_	_
36	and	_	_	CC	_	_	_	_	_
37	Fecalibacterium	_	_	NNP	_	_	_	_	_
38	prausnitzii	_	_	NN	_	_	_	_	_
39	in	_	_	IN	_	_	_	_	_
40	patients	_	_	NNS	_	_	_	_	_
41	on	_	_	IN	_	_	_	_	_
42	a	_	_	DT	_	_	_	_	_
43	low	_	_	JJ	_	_	_	_	_
44	FODMAPs	_	_	NNP	_	_	_	_	_
45	diet	_	_	NN	_	_	_	_	_
46	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	warrants	_	_	VBZ	_	_	_	_	_
3	further	_	_	JJR	_	_	_	_	_
4	investigation	_	_	NN	_	_	_	_	_
5	on	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	potential	_	_	JJ	_	_	_	_	_
8	negative	_	_	JJ	_	_	_	_	_
9	effects	_	_	NNS	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	“	_	_	NN	_	_	_	_	_
12	therapeutic	_	_	JJ	_	_	_	_	_
13	“	_	_	``	_	_	_	_	_
14	diets	_	_	NNS	_	_	_	_	_
15	on	_	_	IN	_	_	_	_	_
16	gut	_	_	NN	_	_	_	_	_
17	microbiota	_	_	NN	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_

